22-30612938-A-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_000355.4(TCN2):c.323A>T(p.Tyr108Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000359 in 1,613,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y108C) has been classified as Uncertain significance.
Frequency
Consequence
NM_000355.4 missense
Scores
Clinical Significance
Conservation
Publications
- transcobalamin II deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000355.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCN2 | NM_000355.4 | MANE Select | c.323A>T | p.Tyr108Phe | missense | Exon 3 of 9 | NP_000346.2 | ||
| TCN2 | NM_001184726.2 | c.323A>T | p.Tyr108Phe | missense | Exon 3 of 9 | NP_001171655.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCN2 | ENST00000215838.8 | TSL:1 MANE Select | c.323A>T | p.Tyr108Phe | missense | Exon 3 of 9 | ENSP00000215838.3 | ||
| TCN2 | ENST00000407817.3 | TSL:1 | c.323A>T | p.Tyr108Phe | missense | Exon 3 of 9 | ENSP00000384914.3 | ||
| TCN2 | ENST00000698271.1 | c.323A>T | p.Tyr108Phe | missense | Exon 3 of 9 | ENSP00000513642.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152084Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251372 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74292 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.323A>T (p.Y108F) alteration is located in exon 3 (coding exon 3) of the TCN2 gene. This alteration results from a A to T substitution at nucleotide position 323, causing the tyrosine (Y) at amino acid position 108 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Transcobalamin II deficiency Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 108 of the TCN2 protein (p.Tyr108Phe). This variant is present in population databases (rs781309237, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with TCN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 566888). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TCN2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at